The result, in preclinical and early clinical data, is maintained blood sugar regulation with reduced nausea and vomiting
The modifications reduce binding to IGF binding proteins, extending its biological half-life relative to native IGF-1
Cagrilintide engages amylin receptors in the area postrema and hindbrain to trigger fullness signals that reduce meal size
These medications slow stomach emptying, reduce hunger signals, and improve insulin sensitivitynone of which directly interfere with the chemical pathways that blood thinners use
Peptides are chains of amino acids, the building blocks of protein, and serve as messengers to the body's cells
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells